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children who received no vaccination 
(22%, 6/27) than among those with 
unknown vaccination history (10%, 
15/157). Of 5 vaccinated children, 1 
had JE; however, verification of this 
child’s vaccination was not possible. 
Among 71 children who had no 
evidence of JE but for whom serum 
samples were available for testing, 5 
had antibodies against mumps virus, 
8 against echoviruses, and 5 against 
coxsackieviruses. Viral cultures of CSF 
from all 189 children were negative.
Our finding of 10.4 JE cases per 
100,000 children <15 years of age in 
Dehong Prefecture is higher than the 
estimated incidence of 5.4 cases per 
100,000 population among children 
<14 years of age in JE-endemic 
countries (2). Nevertheless, the true 
JE population incidence for Dehong 
Prefecture might be underestimated 
if some children received no medical 
care or were admitted to other 
hospitals. Adults were not studied; 
however, ≈90% of JE cases in China 
are reported among children <15 years 
of age (5,6). Unfortunately, accurate 
age-adjusted JE vaccination coverage 
data for Dehong Prefecture are not 
available. Although vaccination 
programs have markedly lowered JE 
incidence in China in recent years 
(5,6), the finding of continuing high 
JE incidence in Dehong Prefecture 
warrants further attention.
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Novel Hantavirus  
in Field Vole,  
United Kingdom
To the Editor: Hantaviruses 
(family Bunyaviridae) are transmit-
ted to humans by inhalation of aero-
solized virus in contaminated urine 
and feces, mainly from rodents of the 
families Cricetidae and Muridae. Al-
though infections in rodents are as-
ymptomatic, infections in humans can 
lead to hemorrhagic fever with renal 
syndrome and hantavirus cardiopul-
monary syndrome (1).
In Europe, 5 rodent-borne hanta-
viruses have been detected: Dobrava-
Belgrade, Saaremaa, Seoul, Puumala, 
and Tula (1,2). The most common 
and widespread hantavirus in Europe 
is Puumala virus, which is associated 
with the mildest form of hemorrhagic 
fever with renal syndrome (1).
In the United Kingdom, only a 
few cases of hantavirus infection in 
humans have been reported and con-
firmed serologically, but the caus-
ative virus species were not identified 
(3,4). Subsequent longitudinal stud-
ies reported considerable hantavirus 
seropositivity among healthy human 
cohorts, suggesting past exposure to 
hantaviruses or subclinical infection 
(3). Serologic surveys of rodents (rats 
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and mice) and cats also supported the 
presence of a hantavirus indigenous to 
the United Kingdom (3). To determine 
whether hantaviruses are circulating 
in wild rodents in the United King-
dom, we conducted molecular analy-
ses on rodent tissues. 
From September 2009 through 
November 2011, a total of 495 wild 
rodents consisting of 133 brown rats 
(Rattus norvegicus), 269 wood mice 
(Apodemus sylvaticus), 50 house 
mice (Mus musculus), 35 bank voles 
(Myodes glareolus), and 8 field voles 
(Microtus agrestis) were caught live 
across northwestern England (online 
Technical Appendix Figure, wwwnc.
cdc.gov/EID/article/19/4/12-1057-
Techapp1.pdf). Animals were eutha-
nized in the field by use of isoflurane 




Within 2 hours, kidney, liver, and lung 
tissues were removed. When field 
conditions allowed, blood samples 
were collected; otherwise, heart tissue 
was collected. Samples, and carcasses 
that could not be processed within 2 
hours, were stored at -80°C. 
RNA was extracted by using 
TRIzol Reagent (Invitrogen, Life 
Technologies, Paisley, UK). To detect 
hantavirus RNA, we used a nested 
pan-hantavirus reverse transcription 
PCR selective for partial polymerase 
large segment (L) gene sequences (5). 
With the exception of 1 male field 
vole (B41) collected near Tattenhall, 
Cheshire (online Technical Appendix 
Figure), all lung samples were nega-
tive for hantavirus RNA. The posi-
tive amplicon was sequenced by us-
ing a BigDye Terminator 3.1v Cycle 
Sequencing Kit on an ABI3130xl 
genetic analyzer (Applied Biosys-
tems/Life Technologies, Paisley, UK) 
(GenBank accession no. JX316008). 
Partial small segment (S) sequences 
were also recovered from lung RNA 
from vole B41 (GenBank accession 
no. JX316009) (online Technical Ap-
pendix Table). Established reverse 
transcription PCRs for the medium 
segment were unsuccessful.
Comparisons of nucleotide and 
amino acid sequence identities dem-
onstrated, as expected, that the Arvico-
linae-associated hantaviruses showed 
the highest similarity to the UK se-
quence at the nucleotide (65.7%–
78.8% for S and 76.6%–77.5% for L) 
and the amino acid (66.4%–86.3% for 
S and 80%–88% for L) levels (online 
Technical Appendix Table).
Phylogenetic analyses of partial 
L (Figure, panel A) and partial S se-
quences (Figure, panel B) confirm the 
inclusion of the viral sequence from 
vole B41 as a distinct member of the 
Arvicolinae-associated hantaviruses. 
In the partial L tree (Figure, panel 
A), viral sequence B41 clustered with 
Prospect Hill and Tula viruses with 
good support, although in the partial 
S tree (Figure, panel B), B41 seems to 






size	values	exceeded	150	 for	partial	L	and	1,600	 for	partial	S	sequences.	The	phylogenetic	position	of	 virus	 isolated	 from	field	vole	
B41	(in	boldface)	is	shown	in	relation	to	representative	hantaviruses	(A)	and	more	closely	related	Arvicolinae-associated	hantaviruses	






es, albeit with low posterior probabil-
ity values. These differences in tree 
topologies probably reflect different 
compositions of the sequence datasets.
Blood collected from vole B41 
was positive for hantavirus-specific 
antibodies (indirect fluorescent anti-
body test that used Puumala antigen) 
(8), suggesting cross-reactivity, as 
would be expected for Arvicolinae-
associated hantaviruses. Hantavirus 
RNA was detected in the kidneys but 
not the liver of vole B41 and not in the 
lungs, liver, or kidneys of the 7 other 
field voles. Degenerate cytochrome B 
gene PCR and sequencing (9) were 
used to confirm the morphologic iden-
tification of the field voles (B41 CytB 
GenBank accession no. KC222031). 
The nucleotide and amino acid 
sequence divergences between B41 
and the most related hantaviruses 
correspond to that typically found 
between hantavirus species (5). The 
phylogenetic analyses further support 
B41 as a distinct hantavirus. Thus, 
we propose to name this novel virus 
Tatenale virus, reflecting the medieval 
name of its place of origin.
M. agrestis voles, among the most 
numerous mammals in mainland Brit-
ain, have not been shown to be primary 
carriers of a specific hantavirus, al-
though recent studies suggest that they 
might be involved in the maintenance 
of Tula virus in Germany (10). Further 
surveillance is needed to confirm that 
M. agrestis voles are the reservoir hosts 
of Tatenale virus, provide an estimate 
of virus prevalence, and determine zoo-
notic risk. Current knowledge of other 
Microtus vole–borne hantaviruses sug-
gests that although they might infect 
humans, their pathogenic potential is 
generally low (1). Future work will in-
volve attempts to isolate Tatenale virus 
and generate its full-genome sequence.
Because hantavirus diseases have 
such broad clinical features, many 
cases among humans in the United 
Kingdom might be misdiagnosed. The 
confirmation of a novel hantavirus 
in indigenous wildlife in the United 
Kingdom might promote inclusion of 
hantavirus infection in the differential 
diagnosis for patients with acute renal 
failure, undiagnosed febrile illness, 
and exposure to rodents (4).
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